"Cell Adhesion Molecules" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.
| Descriptor ID |
D015815
|
| MeSH Number(s) |
D12.776.395.550.200 D12.776.543.550.200 D23.050.301.350
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell Adhesion Molecules".
Below are MeSH descriptors whose meaning is more specific than "Cell Adhesion Molecules".
This graph shows the total number of publications written about "Cell Adhesion Molecules" by people in this website by year, and whether "Cell Adhesion Molecules" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 11 | 3 | 14 |
| 1995 | 14 | 5 | 19 |
| 1996 | 6 | 2 | 8 |
| 1997 | 5 | 3 | 8 |
| 1998 | 4 | 6 | 10 |
| 1999 | 9 | 8 | 17 |
| 2000 | 5 | 7 | 12 |
| 2001 | 5 | 6 | 11 |
| 2002 | 10 | 9 | 19 |
| 2003 | 7 | 3 | 10 |
| 2004 | 14 | 13 | 27 |
| 2005 | 7 | 8 | 15 |
| 2006 | 11 | 13 | 24 |
| 2007 | 6 | 7 | 13 |
| 2008 | 7 | 11 | 18 |
| 2009 | 4 | 10 | 14 |
| 2010 | 9 | 9 | 18 |
| 2011 | 4 | 10 | 14 |
| 2012 | 8 | 6 | 14 |
| 2013 | 8 | 6 | 14 |
| 2014 | 2 | 6 | 8 |
| 2015 | 7 | 5 | 12 |
| 2016 | 4 | 4 | 8 |
| 2017 | 4 | 4 | 8 |
| 2018 | 5 | 3 | 8 |
| 2019 | 3 | 3 | 6 |
| 2020 | 3 | 3 | 6 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 4 | 5 |
| 2024 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Adhesion Molecules" by people in Profiles.
-
TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nat Commun. 2024 Jul 10; 15(1):5291.
-
Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release. Sci Adv. 2024 Jul 12; 10(28):eadk5462.
-
A Potential Role for MAGI-1 in the Bi-Directional Relationship Between Major Depressive Disorder and Cardiovascular Disease. Curr Atheroscler Rep. 2024 Sep; 26(9):463-483.
-
A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels. Blood. 2024 05 02; 143(18):1845-1855.
-
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. J Clin Oncol. 2024 Jul 01; 42(19):2281-2294.
-
Circulating biomarkers in familial cerebral cavernous malformation. EBioMedicine. 2024 Jan; 99:104914.
-
Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma. J Neurosci. 2023 11 22; 43(47):8043-8057.
-
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections. Genet Med. 2024 02; 26(2):101023.
-
Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma. Hum Pathol. 2023 09; 139:117-125.
-
Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage. Am J Hum Genet. 2023 04 06; 110(4):681-690.